IOBT
IO Biotech Inc. Common Stock
$1.500+0.000 (0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.500
High
$1.500
Low
$1.500
Volume
0.38M
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, announced today that
View more
GlobeNewswire
IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights
Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still expected to readout in third quarter of 2025Data presented at recent
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.